The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19).

Published in: Therapeutics and clinical risk management (2020)

Co-administration of fluoxetine in the treatment of COVID19 could be considered due to the possibility of its interaction with ACE2 receptors, immune-modulatory function, and a proper immune response at the right time. Fluoxetine plays a beneficial role in reducing stress due to fear of infecting by COVID19 or worsening the disease and psychological support for the affected patients.

Keyphrases

coronavirus disease
sars cov
immune response
respiratory syndrome coronavirus
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
combination therapy
toll like receptor